AlphaCore Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AlphaCore Capital's PFE Position: Q2 2026 in Review
AlphaCore Capital increased its Pfizer (PFE) stake by 22% in Q2 2026, buying an estimated $983K and bringing the position to 208,486 shares worth $5.02M. The position accounts for 0.09% of the portfolio, ranked #187.
AlphaCore Capital first reported a position in PFE in Q4 2019 and has held it in 20 quarters since. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- AlphaCore Capital held 208,486 shares of Pfizer worth $5.02M as of Q2 2026.
- AlphaCore Capital bought 37,562 Pfizer shares in Q2 2026, an estimated $983K.
- Pfizer made up 0.09% of AlphaCore Capital's portfolio in Q2 2026, its #187 holding.
- AlphaCore Capital first reported a position in Pfizer in Q4 2019 and has held it in 20 quarters since.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.